NeurAxis, Inc. (AMEX:NRXS) Q4 2025 Earnings Call Transcript March 19, 2026 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the NeurAxis, Inc. fourth quarter 2025 financial ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...
Before AI can transform healthcare, someone has to fix the infrastructure underneath it. As Senior Analytics Engineer ...
(“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today ...
NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...
It’s been milestone after milestone for Neurent Medical, an Irish medtech company seeking to tackle chronic rhinitis.
Earlier today, Hyperfine Inc. released financial results for the quarter ending December 31, 2025. Before we begin, I'd like ...
Policy executive Aisha Pittman breaks down the association’s recommendations for innovation in the Medicare Shared Savings Program ...
U.S. medical device companies seeking funding this year will find that innovative tech and a stand-out prototype aren’t ...
Q4 2025 Earnings Call March 18, 2026 4:30 PM EDTCompany ParticipantsMaria Sainz - CEO, President & DirectorBrett Hale - ...
There’s a moment every psychiatrist recognizes. A patient sits down. You have 20 minutes. But their life is not 20 minutes ...
March 21, 2026 • When President Trump says things like “fake news,” “witch hunt” or even “Make America Great Again,” he’s not just using catchy phrases -- he’s persuading people into a way of thinking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results